Abstract
The term apoptosis refers to the morphological process of programmed cell death, a physiological event that occurs at specific stages of normal embryonic development as well as in adult life.1 During programmed cell death, cells undergo profound structural changes. The plasma membrane becomes ruffled or ‘blebbed’. The nucleus shrinks, but the morphology of other cytoplasmic organelles remains relatively unchanged. Within the nucleus, the chromatin condenses, and tends to collapse into patches around the nuclear envelope. Condensation of the chromatin is often accompanied by fragmentation of the DNA, caused by internucleosomal cleavage, resulting in the characteristic ‘ladder’ pattern of bands seen upon electrophoretic separation. The cell may finally break up into apoptotic bodies, which are rapidly phagocytosed.2–4
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L. Sachs, and J. Lotem, Control of programmed cell death in normal and leukemic cells: new implications for therapy, Blood. 82: 15 (1993).
J.F.R. Kerr, A.H. Wyllie, and A.R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer. 26: 239 (1972).
J.J. Cohen, R.C. Duke, V.A. Fadok, and K.S. Sellins, Apoptosis and programmed cell death in immunity, Annu. Rev. Immunol. 10: 267 (1992).
A.H. Wyllie, J.F.R. Kerr, and A.R. Currie, Cell death: the significance of apoptosis, Int. Rev. Cytol. 68: 251 (1980).
J.J. Cohen, Programmed cell death in the immune system, Adv. Immunol. 50: 55 (1991).
C.A. Smith, G.T. Williams, R. Kingston, E.J. Jenkins, and J.J.T. Owen, Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures, Nature 337: 181 (1989).
Y.F. Shi, R.P. Bissonnette, N. Parfray, M. Szalay, R.T. Kuboto, and D.R. Green, In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes, J. Immunol. 146: 3340 (1991).
B. Wang, C. Biron, J. She, K. Higgins, M.J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst, A block in both early T lymphocyte and natural killer cell development in transgenic mice with high copy numbers of the human CD3E gene, Proc. Natl. Acad. Sci. USA 91: 9402 (1994).
J.D. Ashwell, R.E. Cunningham, P.D. Noguchi, and D. Hernandez, Cell growth cycle block of T cell hybridomas upon activation with antigen, J. Exp. Med. 165: 173 (1987).
S. Takahashi, H.T. Maecker, and R. Levy, DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line, Eur. J. Immunol. 19: 1911 (1989).
L. Zhu, and C. Anasetti, Cell cycle control of apoptosis in human leukemic T cells, J. Immunol. 154:192 (1995).
D. Kaebelitz, T. Pohl, and K. Pechhold, Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes, Immunol. Today 147: 338 (1993).
J.H. Russell, B. Rush, C. Weaver, and R. Wang, Mature T cells of autoimmune 1pr/lpr mice have a defect in antigen-stimulated suicide, Proc. Natl. Acad. Sci. USA 90: 4409 (1993).
J. Dhein, H. Waciczak, C. Baumier, K-M. Debatin, and P.H. ‘Crammer, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature 373: 438 (1995).
T. Brunner, R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubl, F. Echeverri, S.J. Martin W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature 373: 441 (1995).
S-T. Ju, D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein, Fas (CD95)/Fas L interactions required for programmed cell death after T-cell activation, Nature 373: 444 (1995).
Y.L. Yang, M. Mercep, C.F. Ware, and J.D. Ashwell, Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas-inhibition of Fas ligand expression by retinoic acid and glucocorticoids, J. Exp. Med. 181: 1673 (1995).
F. Vignaux, E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein, TCR/CD3 coupling to Fas-based cytotoxicity, J. Exp. Med. 181: 781 (1995).
M. Mercep, J.A. Bluestone, P.D. Noguchi, and J.D. Ashwell, Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules, J. Immunol. 140: 324 (1987).
M.J. Lenardo, Interleukin-2 programs mouse aß T lymphocytes for apoptosis, Nature 353: 858 (1991).
S.A. Boehme, and M.J. Lenardo, Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle, Eur. J. Immunol. 23: 1552 (1993).
C. Anasetti, P. Tan, J.A. Hansen, and P.J. Martin, Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen, J. Exp. Med. 172: 1691 (1990).
D.B. Straus, and A. Weiss, Genetic evidence for the involvement of the Ick tyrosine kinase in signal transduction through the T cell antigen receptor, Cell 70: 585 (1992).
N. Oyaizu, S. Than, T.W. McCloskey, and S. Pahwa, Requirement of p561ck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells, Biochem. Biophys. Res. Commun. 213: 994 (1995).
K.M. Murphy, A.B. Heimberger, and D.Y. Loh, Induction by antigen of intrathymic apoptosis of CD4+CD8+TCR10 thymocytes in vivo, Science 250: 1720 (1990).
S.A. Kostelny, M.S. Cole, and J.Y. Tso, Formation of a bispecific mAb by the use of leucine zippers, J. Immunol. 148: 1547 (1992).
A.K. Abbas, A.H. Lichtman, and J.S. Pober, Molecular basis of T cell antigen recognition and activation, in: “Cellular and Molecular Immunology,” W.B. Saunders Co., Philadelphia (1991).
R. Fotedar, J. Flatt, S. Gupta, R.L. Margolis, P. Fitzgerald, H. Messier, and A. Fotedar, Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B, Mol. Cell. Biol. 15: 932 (1995).
A.T. Hoang, K.J. Cohen, J.F. Barrett, D.A. Bergstrom, and C.V. Dang, Participation of cyclin A in myc-induced apoptosis, Proc. Natl. Acad. Sci. USA 91: 6875 (1994).
W. Meikrantz, S. Gisselbrecht, S.W. Tam, and R. Schlegel, Activation of cyclin A- dependent protein kinases during apoptosis, Proc. Natl. Acad. Sci. USA 91: 3754 (1994).
S. Miyatake, H. Nakano, S.Y. Pak, T. Yamazaki, K. Takase, H. Matsushime, A. Kato, and T. Saito, Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas, J. Exp. Med. 182: 401 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chalupny, N.J., Zhu, L., Yu, Xz., Anasetti, C. (1996). Cell Cycle Control of T Cell Apoptosis Induced by Activation Through the T Cell Antigen Receptor. In: Gupta, S., Cohen, J.J. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation VI. Advances in Experimental Medicine and Biology, vol 406. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0274-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0274-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0276-4
Online ISBN: 978-1-4899-0274-0
eBook Packages: Springer Book Archive